Amivantamab-vmjw (Rybrevant, Janssen) is an EGFR and mesenchymal epithelial transition (MET) factor bispecific antibody that targets activating and resistant EGFR and MET mutations and amplifications. Lung cancer scan.
See Original Article

That weighting drops to 12% for senior positions. Tracking the forces driving change. Sign up for the Bloomberg Equality newsletter.
See Original Article

In an interview Friday during the Bloomberg Businessweek virtual summit, Byron said he had spoken with 500 companies, 95% of which were
See Original Article

(Reuters) – The S&P 500 and the Dow rose on Friday, extending a recovery from the previous session, as strong U.S. factory and services activity surveys lifted the mood at the end of a volatile week of trading. FILE PHOTO: People are seen on Wall St. outside …
See Original Article

But hiring “probably wasn’t top three” of Booz Allen’s priorities during the height of the coronavirus pandemic though still one top of mind, CEO Horacio Rozanski said during the company’s fourth quarter earnings call with investors Friday.
See Original Article